Thiourea derivatives, methods of their preparation and their use in neutron capture therapy of malignant melanoma

Patent · Tue Jun 04 00:00:00 EDT 1991

OSTI ID:7273838

Gabel, D

The present invention pertains to boron containing thiouracil derivatives, their method of preparations, and their use in the therapy of malignant melanoma using boron neutron capture therapy. No Drawings

• DOE Contract Number: AC02-76CH00016
• Assignee: Dept. of Energy, Washington, DC (United States)
• Patent Number(s): US 5021572; A
• Application Number: PPN: US 7-302289
• OSTI ID: 7273838
• Resource Relation: Patent File Date: 27 Jan 1989
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
BORON
LABELLING
MELANOMAS
NEUTRON CAPTURE THERAPY
RADIOPHARMACEUTICALS
CHEMICAL PREPARATION
THIOURACIL
UPTAKE
ANTIMETABOLITES
ANTITHYROID DRUGS
AZINES
CARCINOMAS
DISEASES
DRUGS
ELEMENTS
EPITHELIOMAS
HETEROCYCLIC COMPOUNDS
HORMONE ANTAGONISTS
HYDROXY COMPOUNDS
LABELLED COMPOUNDS
MEDICINE
NEOPLASMS
NEUTRON THERAPY
NUCLEAR MEDICINE
ORGANIC COMPOUNDS
ORGANIC NITROGEN COMPOUNDS
ORGANIC SULFUR COMPOUNDS
PYRIMIDINES
RADIOLOGY
RADIOTHERAPY
SEMIMETALS
SYNTHESIS
THERAPY
THIOLS
URACILS
550604* - Medicine- Unsealed Radionuclides in Therapy- (1980-)